Regular sauna use to lower blood pressure in primary aldosteronism
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether regular sauna sessions (about 1 hour) can help lower blood pressure in people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone hormone, leading to high blood pressure. You'll use the HiLo app to track your sessions and blood pressure over 6 weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and have been diagnosed with primary aldosteronism (a hormone condition that causes high blood pressure).
- Your blood pressure is still not under control (above 140/90 in the clinic or above 135/85 on a 24-hour monitor).
- Your blood pressure medicines have not changed in the last 6 weeks.
- You eat a moderate or higher salt diet (more than about 1 teaspoon per day).
- You own an iPhone (12-16) or Android phone and are willing to install the HiLo app.
- You are not planning any surgery or major changes, and have not had a heart attack, chest pain, heart failure, or an irregular heartbeat in the past 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine, SAL0140, for people with primary aldosteronism, a condition where the adrenal glands make too much aldosterone, causing high blood pressure. The study aims to see if the drug can lower blood pressure and improve health.
This trial looks at whether adding spironolactone to your current blood pressure medicines works better for people with primary aldosteronism (a condition where your adrenal glands make too much aldosterone, raising blood pressure). You may qualify if you have this form of high blood pressure but have declined surgery or don't have an adenoma.
This study tests if a 2-day version of the oral salt loading test works as well as the standard 3-day test to diagnose primary aldosteronism (a common cause of high blood pressure). If effective, it could make diagnosis faster and easier for patients.
This study examines how different methods of measuring hormone levels in the blood help identify primary aldosteronism (a condition causing high blood pressure). Researchers want to find the best cutoff values to identify patients who might benefit from surgery to remove part of the adrenal gland.
This study looks at better ways to diagnose primary aldosteronism when lab results suggest the condition but standard diagnosis criteria haven’t been met. It may help you understand what your hormone pattern means and whether you need specific treatment.
This study tests a new drug called QLS1410 for people with primary aldosteronism, a condition that causes high blood pressure due to too much aldosterone. The drug aims to lower blood pressure and improve health, potentially offering a new treatment option.
Hear when a new Primary Aldosteronism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.